Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 10, 1998, Pages 701-708

  Kuikka, A ^a   Valtonen, V V ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM; CIPROFLOXACIN; PARACETAMOL;

ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOOD VESSEL CATHETERIZATION; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE COURSE; FATALITY; FEMALE; FINLAND; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHOCK; STATISTICAL ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URETER CATHETERIZATION;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; FEMALE; FINLAND; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032436388     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050164     Document Type: Article

References (31)

1. 1. Arpi M, Victor MA, Moller JK, Jonsson V, Hansen MM, Peterslund NA, Bruun B: Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scandinavian Journal of Infectious Diseases 1994, 26:157-162
2. 2. Gonzalez BE, Fernandez SA, Carratala J, Granena A, Gudiol F: Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15:291-296
3. 3. Johansson PJ, Sternby E, Ursing B: Septicemia in granulocytopenic patients: a shift in bacterial etiology. Scandinavian Journal of Infectious Diseases 1992, 24:357-360
4. 4. Kiehn TE, Armstrong D: Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9:869-872
5. 5. Pittet D, Wenzel RP: Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Archives of Internal Medicine 1995, 155:1177-1184
6. 6. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB: The clinical significance of positive blood cultures in the 1990 s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clinical Infectious Diseases 1997, 24:584-602
7. 7. Baltch AL, Griffin PE: Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. American Journal of the Medical Sciences 1977, 274:119-129
8. 8. Bodey GP, Jadeja L, Elting L: Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Archives of Internal Medicine 1985, 145:1621-1629
9. 9. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR: Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. American Journal of Medicine 1989, 87:540-546
10. 10. Mallolas J, Gatell JM, Miro JM, Marco F, Bisbe J, Jimenez, de, Anta, Mt, Soriano E: Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia. Antibiotics and Chemotherapy 1991, 44:106-114
11. 11. Vazquez F, Mendoza MC, Villar MH, Vindel A, Mendez FJ: Characteristics of Pseudomonas aeruginosa strains causing septicemia in a Spanish hospital 1981-1990. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11:698-703
12. 12. Vidal F, Mensa J, Almela M, Martinez JA, Marco F, Casals C, Gatell JM, Soriano E, Jimenez, de, Anta, Mt: Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Archives of Internal Medicine 1996, 156:2121-2126
13. 13. Flick MR, Cluff LE: Pseudomonas bacteremia. Review of 108 cases. American Journal of Medicine 1976, 60:501-852
14. 14. Gallagher PG, Watanakunakorn C: Pseudomonas bacteremia in a community teaching hospital, 1980-1984. Reviews of Infectious Diseases 1989, 11:846-852
15. 15. Chen SC, Lawrence RH, Byth K, Sorrell TC: Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor? Medical Journal of Australia 1993, 159:592-597
16. 16. Fergie JE, Shema SJ, Lott L, Crawford R, Patrick CC: Pseudomonas aeruginosa bacteremia in immunocompromised children: analysis of factors associated with a poor outcome. Clinical Infectious Diseases 1994, 18:390-394
17. 17. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Approved Standard M100-S5 NCCLS. Villanova, PA, 1994
18. 18. Hosmer DW, Lemeshow S: Applied logistic regression. Wiley-Interscience, New York, 1989
19. 19. Dixon WJ (ed): BMDP statistical software manual. University of California Press, Los Angeles, 1992
20. 20. McCabe WR, Jackson GG: Gram-negative bacteraemia. Archives of Internal Medicine 1962, 110:847-864
21. 21. Kuikka A, Sivonen A, Emelianova A, Valtonen VV: Prognostic factors associated with improved outcome of Escherichia coli bacteremia in a Finnish university hospital. European Journal of Clinical Microbiology & Infectious Diseases 1997, 16:125-134
22. 22. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL: Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Annals of Internal Medicine 1991, 115:585-590
23. 23. Korvick JA, Bryan CS, Farber B, Beam TJ, Schenfeld L, Muder RR, Weinbaum D, Lumish R, Gerding DN, Wagener MM, et al: Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrobial Agents and Chemotherapy 1992, 36:2639-2644
24. 24. Bisbe J, Gatell JM, Puig J, Mallolas J, Martinez JA, Jimenez, de, Anta, Mt, Soriano E: Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Reviews of Infectious Diseases 1988, 10:629-635
25. 25. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA: The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Reviews of Infectious Diseases 1983, 5:54-70
26. 26. Bryant RE, Hood AF, Hood CE, Koenig MG: Factors affecting mortality of gram-negative rod bacteremia. Archives of Internal Medicine 1971, 127:120-128
27. 27. Ehni WF, Reller LB, Ellison RT: Bacteremia in granulocytopenic patients in a tertiary-care general hospital. Reviews of Infectious Diseases 1991, 13:613-619
28. 28. Rolston KV, Bodey GP: Pseudomonas aeruginosa infection in cancer patients. Cancer Investigation 1992, 10:43-59
29. 29. Mosca R, Curtas S, Forbes B, Meguid MM: The benefits of Isolator cultures in the management of suspected catheter sepsis. Surgery 1987, 102:718-723
30. 30. Benezra D, Kiehn TE, Gold JW, Brown AE, Turnbull AD, Armstrong D: Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. American Journal of Medicine 1988, 85:495-498
31. 31. Rubin M, Hathorn JW, Pizzo PA: Controversies in the management of febrile neutropenic cancer patients. Cancer Investigation 1988, 6:167-184